- Home
- ZBH vs WAT Comparison
ZBH vs WAT Comparison
Compare ZBH & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBH
- WAT
- Stock Information
- Founded
- ZBH 1927
- WAT 1958
- Country
- ZBH United States
- WAT United States
- Employees
- ZBH N/A
- WAT N/A
- Industry
- ZBH Industrial Specialties
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- ZBH Health Care
- WAT Industrials
- Exchange
- ZBH Nasdaq
- WAT Nasdaq
- Market Cap
- ZBH 19.1B
- WAT 17.8B
- IPO Year
- ZBH N/A
- WAT 1995
- Fundamental
- Price
- ZBH $92.04
- WAT $281.15
- Analyst Decision
- ZBH Hold
- WAT Hold
- Analyst Count
- ZBH 20
- WAT 14
- Target Price
- ZBH $112.33
- WAT $374.07
- AVG Volume (30 Days)
- ZBH 1.8M
- WAT 1.3M
- Earning Date
- ZBH 08-07-2025
- WAT 08-04-2025
- Dividend Yield
- ZBH 1.04%
- WAT N/A
- EPS Growth
- ZBH N/A
- WAT 10.77
- EPS
- ZBH 4.51
- WAT 11.09
- Revenue
- ZBH $7,698,500,000.00
- WAT $3,046,056,000.00
- Revenue This Year
- ZBH $7.64
- WAT $6.27
- Revenue Next Year
- ZBH $5.64
- WAT $6.49
- P/E Ratio
- ZBH $20.42
- WAT $25.37
- Revenue Growth
- ZBH 3.30
- WAT 5.89
- 52 Week Low
- ZBH $89.22
- WAT $279.19
- 52 Week High
- ZBH $116.71
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- ZBH 43.95
- WAT 30.82
- Support Level
- ZBH $89.33
- WAT $279.19
- Resistance Level
- ZBH $97.92
- WAT $305.75
- Average True Range (ATR)
- ZBH 2.03
- WAT 9.23
- MACD
- ZBH -0.46
- WAT -0.29
- Stochastic Oscillator
- ZBH 31.55
- WAT 7.35
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.